ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01125293
Brief Title: Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia

First Submitted : March 16, 2010
First Submitted that Met QC Criteria : May 17, 2010
First Posted : May 18, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : October 12, 2017
Last Update Posted : October 16, 2017